Additionally, parametric effects on the drug's release behaviour from the Brij micelle containing DT were examined. However, DT's bioactive potential may be hampered during entrapment by the micellization process and subsequent release of the drug. Hence, various quality parameter tests were conducted before and after DT's release from the produced micelle. For its continued use, it is crucial to determine if the released DT from the micelle retains its bioactive properties. Thus, DT's antibacterial bioactivity was assessed on live bacterial strains following its release. Moreover, DT's ADMET (absorption, distribution, metabolism, excretion, and toxicity) analysis and prediction of probable targets associated with important diseases were done through in silico mode to understand its effect on human body after entering through oral route. Moreover, molecular docking and statistical analysis were also done to check the validation of the outcomes.